Advanced Vitreoretinal Techniques & Technology Symposium

Similar documents
Advanced Vitreoretinal Techniques & Technology Symposium

Advanced Vitreoretinal Techniques

SALLY 46TH. 46th Sally Letson Symposium September 18-20, 2014 The Global Impact of Retinal Innovations

2015 Ophthalmic Imaging INVITED GUESTS

JANUARY 27-29, TH ANNUAL Retina Fellows Forum. Westin Chicago River North Chicago, IL

Saturday, February 9, a.m. 2:30 p.m.

JANUARY. 19TH ANNUAL Retina Fellows Forum. Westin Chicago River North, Chicago, IL

Years. April 27-29, 2018 Halekulani Hotel & Spa

The Wilmer Eye Institute s 34 th Annual Current Concepts in Ophthalmology March 13-17, 2017 Vail Marriott * Vail, Colorado

The Wilmer Eye Institute s 34 th Annual Current Concepts in Ophthalmology March 13-17, 2017 Vail Marriott * Vail, Colorado

Medical & Surgical Retina Update

FINAL PROGRAM TRENDS IN SURGICAL III. Borja Corcóstegui, MD IMO - Barcelona May 29th & 30th 2015, Barcelona

MONDAY, JANUARY 22 nd

Vanderbilt Eye Institute Clinical Trials

Darren J. Bell, M.D. Texas A&M University College of Medicine College Station, Texas Doctor of Medicine

SCIENTIFIC PROGRAM. Monday, June 13, :00 19:00 Registration 00:00 20:00 Reception Cocktail Tuesday, June 14, 2016

2ND ANNUAL TRANSFORMATIONAL OPHTHALMOLOGY SYMPOSIUM

SCIENTIFIC PROGRAM. Pediatric ophthalmology- Optometry challenges (max 20 attendees)

Sudden Vision Loss. Brendan Girschek, MD, FRCSC, FACS Vitreoretinal Surgery Cedar Valley Medical Specialists

Financial Disclosures

Diabetic Macular Edema Treatment in the 21st Century

SPINE FINAL PROGRAM SCHEDULE. AAOS Board Maintenance of Certification Preparation and Review. November 4, 2017 Boston, MA. A.

Low Illumination 3-D Heads-Up Vitrectomy for Diabetic Macular Edema

October 21, am 3 pm. Second Annual Updates in Clinical and Surgical Gynecology. CME Symposium

Ophthalmic VEGF Inhibitors. Eylea (aflibercept), Macugen (pegaptanib) Description

2014 NY COURSE DIRECTOR CARL C. AWH, MD COURSE CO-DIRECTORS DAVID R. CHOW, MD TAREK S. HASSAN, MD CME ACCREDITATION AND CREDIT DESIGNATION

Cases, cases...foiled again. A day with the neuro experts. Saturday, September 10, 2016 Cole Eye Institute, James P. Storer Conference Center

Ophthalmology Macular Pathways

SURGICAL VITREORETINAL FELLOWSHIP PROGRAM. UNIVERSITY OF KENTUCKY AND RETINA ASSOCIATES OF KENTUCKY Lexington, Kentucky

Office Based Practice. Vitreoretinal Disease & Surgery. Coding Fiesta Vitreoretinal Disease & Surgery September 23, 2017 ADULT RETINA

Diagnostic Sonography Symposium

MARCH 29, th Annual Meeting. Pittsburgh Marriott City Center 112 Washington Ave Pittsburgh PA Pittsburgh Opthalmology Society

New Insights on Treating Diabetic Retinopathy & Diabetic Macular Edema from the 2018 AAO Meeting

Stanford Breast in the West: Multi-Modality Breast Imaging Symposium for Radiologists

MAYO CLINIC RETINA UPDATE & CASE CONFERENCE

CANADIAN RETINA SOCIETY INAUGURAL MEETING

UVEITIS Fellows Forum

Ophthalmology. Juliette Stenz, MD

CLINICAL CHALLENGES in Diagnosis and Treatment of Eye Disease

II Ophthalmic Spring Academy. May 20 th -24 th 2014 Cracow, Hotel Galaxy

04/11/2014. Retina Coding and Reimbursement 101. Financial Disclosure. Chief Complaint

The College of Optometrists - Learning outcomes for the Professional Certificate in Medical Retina

04/06/2015. Documentation Do s and Don ts In The Retina Practice. Financial Disclosure. Documentation Dos and Don ts

Ophthalmology: Advocacy, Leadership, Legacy, and Learning

The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care

UPDATES IN NEPHROLOGY FOR THE PRIMARY CARE PROVIDER SATURDAY, MAY 5, 2018 THE INN AT ST. JOHN S, PLYMOUTH, MI

Advances in Epilepsy and EEG

8th HIPPOCRATIC MEETING 27&28 MARCH 2015 RETINA MACULA VITREOUS MAKEDONIA PALACE / THESSALONIKI

Clinical Applications of Proton Beam Irradiation in Ophthalmology April 8, 2011

Ophthalmology in View: Vision, Innovation, Enterprising, & Worldwide Impact

SATURDAY FEBRUARY 23, 2013

MEMORIAL LECTURE & RESIDENT ABSTRACT COMPETITION 6TH ANNUAL DR. JOHN MORDENTE WEDNESDAY, OCTOBER 18, :00 PM 9:30 PM

Fifth Annual Advances in Pulmonary and Critical Care Medicine CME Symposium

Health Delivery and Technology in Today s DIABETES CARE

Retina 2014 Highlights and Hallmarks

Although photocoagulation and photodynamic PROCEEDINGS PEGAPTANIB SODIUM FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION *

2019 ANNUAL MEETING SOUTH CAROLINA RHEUMATISM SOCIETY MARCH 29 31, 2019 HYATT PLACE CHARLESTON. 560 King Street Charleston, South Carolina

The Arthur C. Nielsen, Jr. Vascular Symposium: A Clinical Update on Vascular Medicine and Surgery

Retinal Diseases. Age-Related Macular Degeneration. What Is AMD? Risk Factors for AMD

CENTENE PHARMACY AND THERAPEUTICS NEW DRUG REVIEW 2Q17 April May

Moncef Khairallah, MD

Essentials of Primary Care Pain Management Conference

CLINICAL ENDOCRINOLOGY FOR PRIMARY CARE

The 2016 Northwestern Brain Tumor Institute

When to Refer to RETINA. Joseph M. Coney, MD February 17, 2017 Memphis, TN

Friday, April 20, 2018

March 15, 2019 California NanoSystems Institute at UCLA

Progressive Symptomatic Retinal Detachment Complicating Retinoschisis. Initial Reporting Questionnaire


2018 HEALTHCARE OUTCOMES PERFORMANCE SYMPOSIUM (HOPS) EVENT FACT SHEET

Diagnosis and treatment of diabetic retinopathy. Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City

The Foundation WHAT IS THE RETINA? continued next page. RETINA HEALTH SERIES Facts from the ASRS

THE NEUROHOSPITALIST SOCIETY

The Economic$ and Epidemiology of Intravitreal Injections

Swept-Source Optical Coherence Tomography

Second Annual Spine Surgery Symposium

Learn more: chop.cloud-cme.com

Hong Kong College of Surgical Nursing

PAWAN BHATNAGAR, M.D.


Wet Age-Related Macular Degeneration

Current Management of Prevalent Cardiovascular Diseases

Frankfurt Retina Meeting

Join us for the Fourth Annual Neurohospitalist Society Meeting

A Patient s Guide to Diabetic Retinopathy

CURRICULUM VITAE LORY CECILIA SNADY-McCOY, M.D.

Acute Retinal Necrosis Secondary to Varicella Zoster Virus in an Immunosuppressed Post-Kidney Transplant Patient

RECOGNIZING & ASSESSING COGNITIVE IMPAIRMENT SYMPOSIUM

Customized Facial Implants and 3-Dimensional Surgical Planning:

PROSPECTIVE THREE-DIMENSIONAL ANALYSIS OF STRUCTURE AND FUNCTION IN VITREOMACULAR ADHESION CURED BY PHARMACOLOGIC VITREOLYSIS

Accommodations. Neurosurgeons, Spine Surgeons. Spine and Neurosurgery clinicians. Spine and Neurosurgery Residents and Fellows.

THE ROLE OF anti-vegf IN DIABETIC RETINOPATHY AND AGE RELATED MACULAR DEGENERATION

Practical Care of the Cataract Patient with Retinal Disease

Barcelona, 3 4 June 2011 Auditorium IMO (Institut de Microcirurgia Ocular)

Dan Roberts. International Low Vision Support Group NEWSLETTER. This Month. In This Issue. 1: This Month 2-5: News

APRIL 11 th, Milan, NH Milano 2. CHAIRMAN Francesco Bandello, MD, FEBO

Dr Mallika Goyal, MD, DNBE

ENDOCRINOLOGY FOR PRIMARY CARE

Practical Update in Cardiology 2017

VEGF Trap-Eye: New Data Confirm Successes in the Treatment of Age-related Macular Degeneration

Transcription:

14th ANNUAL Advanced Vitreoretinal Techniques & Technology Symposium JULY 25-27, 2014 SWISSÔTEL CHICAGO CHICAGO, IL CME ACCREDITATION AND CREDIT STATEMENT This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of William Beaumont Hospital and Medical Conference Planners, Inc. William Beaumont Hospital is accredited by the ACCME to provide continuing medical education for physicians. William Beaumont Hospital designates this live activity for a maximum of 21.25 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity. (Credit breakdown: Friday=9.50, Saturday=7.75, Sunday=4.00) Non-physician professionals should check with their individual credentialing bodies to confirm that participation in this CME activity will be approved for credit. CME credits can be used to meet the continuing education requirements for Michigan physician assistant and nursing relicensure without limitation.

SYM P OSIUM FAC ULT Y Assistant Professor of Ophthalmology Illinois Eye and Ear Infirmary Professor of Ophthalmology Feinberg School of Medicine Northwestern University Professor & Chairman, Dept. of Ophthalmology Rush University Medical Center Retinal Consultants of Arizona Chaney Family Endowed Chair for Ophthalmology Research Professor of Ophthalmology, Cleveland Clinic Lerner College of Medicine Cole Eye Institute Professor of Ophthalmology Director, Medical Retina Unit, Ophthalmic Imaging Unit, Doheny Image Reading Center Doheny Eye Institute/UCLA Associate Director, Retina Service, MEEI S.E. Gragoudas Associate Professor of Ophthalmology Harvard Medical School JENNIFER J. KANG-MIELER, PhD Associate Professor of Biomedical Engineering Dept. of Biomedical Engineering, Pritzker Institute of Biomedical Science and Engineering Illinois Institute of Technology Clinical Assistant Professor of Ophthalmology Illinois Eye and Ear Infirmary Associate Professor, Dept. of Ophthalmology Feinberg School of Medicine Northwestern University YANNEK I. LEIDERMAN, MD, PhD Assistant Professor of Ophthalmology Illinois Eye and Ear Infirmary Chairman, Dept. of Ophthalmology William Beaumont Hospital/ Associated Retinal Consultants Clinical Professor of Ophthalmology, NYU School of Medicine Vitreous Retina Macula Consultants of New York Professor of Ophthalmology Illinois Eye and Ear Infirmary S Y M P O S I U M O R G A N I Z E R Professor of Ophthalmology, Retina Service Interim Department Head Vice Chair for Education DEBRA A. GOLDSTEIN, MD Professor, Director Uveitis Service Dept. of Ophthalmology Northwestern Memorial Hospital Feinberg School of Medicine Northwestern University Professor of Ophthalmology, Retina Service Interim Department Head Vice Chair for Education A V T T 2 014 3

AVTT 2014 PROGRAM FRIDAY, JULY 25 7:00 AM 5:30 PM Registration 7:00 AM 7:55 AM fast 7:00 AM 1:15 PM Exhibits 7:55 AM 12:30 PM Best Practice in Ophthalmology Vitreoretinal Fellows Program 7:55 AM Introduction and Welcome 8:00 AM Ophthalmic Workforce and the Economics of Vitreoretinal Practice 8:15 AM New Payment Methods for Physicians 8:30 AM What is the RUC, and New Issues in Retinal Coding 8:45 AM Improving Patient Satisfaction in Vitreoretinal Practice 9:00 AM Audits: Here, There, and Everywhere 9:15 AM Off-Label Drug Usage and the Law 9:30 AM Risk Management, and Avoiding a Lawsuit 9:45 AM Ethics Round Table with Entire Faculty MODERATOR: 10:00 AM 10:30 AM 10:30 AM Incorporating Clinical Research and Clinical Trials into your Practice 10:45 AM The Current Status of Vitreoretinal Fellowship Accreditation and Certification 11:00 AM : Type of Practice, Pros and Cons of Academics, Private Practice and/or a Mixed Type of Practice, or Being a Chairman? ALL FACULTY 11:15 AM Activity Based Costing: Do You Really Know What is Profitable? 11:30 AM Maintaining Quality in a High Volume Practice Setting 11:45 AM Important Factors to Consider in Choosing a Practice: Contract Management/Partners/Location ALL FACULTY 12:15 PM Advocacy: Why You Should Participate 12:30 PM 1:15 PM Lunch 1:15 PM 5:30 PM Vitrectomy Instrument Demonstration and of Challenging OCT, Medical, and Surgical Cases for the Vitreoretinal Fellows (Vitreoretinal Fellows and Residents will be separated into two groups for the interactive sessions.) GROUP 1 1:15 PM 3:15 PM Vitrectomy Instrument Demonstration 3:15 PM 3:30 PM 3:30 PM 5:30 PM of OCT, Medical and Surgical Cases 4 A V T T 2 014

GROUP 2 1:15 PM 3:15 PM of OCT, Medical and Surgical Cases 3:15 PM 3:30 PM 3:30 PM 5:30 PM Vitrectomy Instrument Demonstration 5:30 PM 7:00 PM Hands-on Vitrectomy Instrument Usage and Reception ALL FACULTY SATURDAY, JULY 26 6:45 AM 5:00 PM Registration 6:45 AM 7:25 AM fast 6:45 AM 5:00 PM Exhibits 7:25 AM 9:30 AM Retinal Imaging and Technology MODERATOR: 7:25 AM Introduction 7:30 AM OCT and the Next Generation of OCT (Swept Source) 7:45 AM EDI-OCT: How Helpful is it in the Management of Choroidal Disease? 8:00 AM OCT of Vitreomacular Interface Disorders 8:15 AM Fundus Autofluorescence in Clinical Practice 8:30 AM The Utility of Wide-Angle Imaging (Is it Essential for Practice?) 8:45 AM Doppler OCT: Functional Imaging of Blood Flow 9:00 AM Multi-Modal Imaging of White Spot Syndromes; Is it Helpful in Diagnosis and Treatment? 9:15 AM Image Management Solutions for a Busy Practice 9:30 AM 10:00 AM 10:00 AM 10:30 AM Vitreoretinal Surgery and Techniques MODERATOR: 10:00 AM Fluidics, Tips and Tricks for Small Gauge Vitrectomy Surgery 10:15 AM Management of Silicone Oil: Getting it Just Right 10:30 AM Combination PPV and Cataract Surgery; Are Outcomes of Combination or Sequential Surgery Different? 10:45 AM Retinal Techniques for IOL Re-positioning and/or Replacement 11:00 AM The Timing of Surgery for Repair of a Primary Retinal Detachment 11:15 AM Repair of Retinal Detachment after Open-Globe Injury 11:30 AM 11:45 AM DEBATE #1: Initial Treatment of a Macular Hole with Vitreomacular Adhesion MODERATOR: A V T T 2 014 5

11:30 AM Pharmacologic Vitreolysis 11:35 AM Vitrectomy Surgery 11:40 AM 11:45 AM 12:00 PM DEBATE #2: High-Speed (>5000 cpm) and Small Gauge (27 gauge) Vitrectomy Machines Have Revolutionized Our Surgery and Improved Our Outcomes MODERATOR: 11:45 AM PRO: Our Outcomes Have Been Dramatically Improved 11:50 PM CON: The High-Speed Machines Have Minimally Enhanced Our Outcomes 11:55 PM 12:00 PM 1:00 PM Lunch 1:00 PM 3:00 PM Diabetic Retinopathy and DME MODERATOR: 1:00 PM Pathophysiology of Diabetic Retinopathy 1:15 PM DRCR: Past, Present and Future 1:30 PM Treatment Algorithm for DME 1:45 PM Corticosteroid Drug Delivery Devices: Paradigm Shift in the Management of DME? 2:00 PM Surgery for DME: Is it Beneficial? 2:15 PM Surgical Treatment of Proliferative Diabetic Retinopathy 2:30 PM Evidence Based Treatment for DME: What is Truly Cost Effective? 2:45 PM Systemic Safety of Anti-VEGF Therapy: Is There Cause for Concern? 3:00 PM 3:30 PM 3:30 PM 3:45 PM VASCULAR DISEASE DEBATE #1: What Determines the Need for Initial Treatment of Diabetic Macular Edema? MODERATOR: 3:30 PM OCT 3:35 PM Visual Acuity 3:40 PM 3:45 PM Update Regarding Treatment of Venous Occlusive Disease 4:00 PM 4:15 PM VASCULAR DISEASE DEBATE #2: Initial Treatment of Venous Occlusive Disease MODERATOR: 4:00 PM Anti-VEGF Therapy All the Way 4:05 PM Corticosteroids are the Best Starting Medication 4:10 PM 4:15 PM 5:15 PM Miscellaneous MODERATOR: 4:15 PM Pediatric Retina Update 4:30 PM Adult ROP 6 A V T T 2 014

4:45 PM Uveal Melanoma Update 5:00 PM More OCT Mystery Cases 5:15 PM 6:15 PM Reception SUNDAY, JULY 27 6:45 AM 12:00 PM Registration 6:45 AM 7:25 AM fast 6:45 AM 10:00 AM Exhibits 7:25 AM 9:30 AM AMD and Retinal Degenerations MODERATOR: 7:25 AM Introduction 7:30 AM AREDS2 Update 7:45 AM New Drugs in the Pipeline for Dry AMD (Is a Significant through Coming Soon?) 8:00 AM New Drugs in the Pipeline for Wet AMD (Beyond Anti-VEGF) 8:15 AM En Face OCT Findings in AMD and Reticular Pseudodrusen 8:30 AM The Role of Imaging in the Management of AMD 8:45 AM New Findings in Polypoidal Vasculopathy 9:00 AM Gene Therapy, Artificial Vision and the Argus II Implant 9:15 AM Drug Delivery Systems Update JENNIFER J. KANG-MIELER, PhD 9:30 AM 10:00 AM 10:00 AM 10:15 AM DEBATE: Genetic Testing and AMD MODERATOR: PRAVIN U. DUGEL 10:00 AM PRO: Genetic Testing Should Routinely be Performed for AMD as it Impacts Potential Management 10:05 AM CON: Genetic Testing is Currently NOT Indicated 10:10 AM 10:15 AM 12:00 PM Infection and Inflammation MODERATOR: 10:15 AM Endophthalmitis Update 2014 10:30 AM The Nuances of Safely Giving an Intravitreal Injection 10:45 AM What s New in Intravitreal Therapy for Uveitis? DEBRA A. GOLDSTEIN, MD 11:00 AM Ocular Lymphoma: Varying Clinical Manifestations 11:15 AM Ocular Lymphoma: Confirmation of Diagnosis, and Treatment 11:30 AM Ocular Manifestations of Tuberculosis DEBRA A. GOLDSTEIN, MD 11:45 AM The Numerous Manifestations of Ocular Syphilis DEBRA A. GOLDSTEIN, MD 12:00 PM Meeting Adjourned A V T T 2 014 7

This CME activity is supported by an educational grant from: E X H I B I TO R S AVTT acknowledges generous contributions from the following companies: PLATINUM Genentech, Inc. GOLD Regeneron Pharmaceuticals, Inc. SILVER Alcon Laboratories, Inc. Allergan, Inc. Insight Instruments, Inc. OCULUS Surgical, Inc. Quantel Medical, Inc. Synergetics, Inc. Medical Conference Planners, Inc. 914-722-0664 avtt@medconfs.com www.medconfs.com